Skip to main content

Table 1 Preoperative demographic data, clinical characteristics and severity of coronary heart disease in 910 patients surviving two months after CABG

From: Associations of metabolic syndrome and diabetes mellitus with 16-year survival after CABG

 

DM–/MetS–

DM–/MetS+

DM+

Overall

 

n = 375

n = 279

n = 256

p-value

Female (%)

15.2

26.2

23.8

<0.011,2

Mean Age (years) (SD)

61.3 (8.2)

60.7 (8.6)

63.3 (8.4)

<0.0012,3

Variables of Modified MetS

BMI (kg/ m 2 )

25.8

28.7

28.1

NA

Elevated Blood Pressure (%)

40.9

83.1

67.5

 

HDL Cholesterol (low, %)

44.9

90.2

65.3

 

Triglyceride (high, %)

27.4

83.7

67.7

 

Elevated Glucose or DM (%)

4.5

25.8

100.0

 

Concomitant Diseases

Hypercholesterolemia (%)

69.5

80.3

77.7

NS

Previous MI (%)

70.5

67.8

67.7

NS

Previous TIA or stroke (%)

8.9

8.6

13.9

NS

Intermittent Claudication (%)

6.2

4.7

18.6

<0.0013,4

Renal Function

CreaCl (ml/min) (SD)

76.4 (13.8)

74.2 (18.2)

73.7 (16.9)

NS

CreaCl < 60 ml/min/1,73 m 2 (%)

11.0

19.0

19.7

<0.011,2

Preoperative Smoking (%)

66.6

60.2

66.4

NS

Severity of Heart Disease

EF (%) (SD)

60 (14)

61 (13)

58 (14)

<0.055

EF ≤ 35% (%)

7

4

11

<0.055

NYHA II (%)

11.9

13.0

6.5

 

NYHA III (%)

59.9

54.3

56.3

<0.055

NYHA IV (%)

28.2

32.6

37.2

 

Operation Characteristics

Three–vessel Disease (%)

61.1

59.7

58.6

NS

Left Main Disease (%)

13.1

16.6

14.1

NS

Number of Grafts

3.39

3.38

3.35

NS

Use of Arterial Grafts (%)

86.3

83.4

81.0

NS

Concomitant Operation (%)

6.1

3.3

7.6

NS

Perfusion Time (SD)

107.0 (36.6)

108.0 (58.8)

112.3 (34.2)

NS

Urgent or Emergency Operation (%)

26.7

29.9

33.5

NS

  1. Abbreviations: MI myocardial infarct, TIA transient ischemic attack, EF ejection fraction, NYHA angina pectoris symptoms according to New York Heart Association, CHD coronary heart disease, LM left main, low HDL cholesterol: men < 1.03 mmol/l, women < 1.3 mmol/l, elevated triglycerides: ≥ 1.7 mmol/l, NS = not significant, NA = not applicable.
  2. 1Unadjusted p < 0.01 by the pooled t-test for the comparison DM-/MetS+ against DM-/MetS-.
  3. 2Unadjusted p < 0.01 by the pooled t-test for the comparison DM+ against DM-/MetS-.
  4. 3Unadjusted p < 0.001 by the pooled t-test for the comparison DM+ against DM-/MetS+.
  5. 4Unadjusted p < 0.001 by the pooled t-test for the comparison DM+ against DM-/MetS-.
  6. 5Unadjusted p < 0.05 by the pooled t-test for the comparison DM+ against other groups.